Director Miyazaki to deliver lecture at The 33rd Japanese Association for Renal Failure Surgery

• Title: Creation of a new medical treatment for end stage kidney failure with AIM
• Date: July 13, 2024 (Saturday)
• Venue: Hotel Buena Vista, Matsumoto

Vice director Arai presented at EMBO/EMBL Symposium

• Date: June 20, 2024
• Venue: EMBL Advanced Training Centre, Heidelberg, Germany

Director Miyazaki to deliver lecture at The 69th Annual Meeting of the Japanese Society for Dialysis Therapy

• Title: Creation of a new medical treatment for end stage kidney failure with AIM
• Date: June 7, 2024 (Friday) 8:20～9:20
• Venue: Pacifico Yokohama

Doctoral student Kazuhiro Ishii* participates at the 46th Annual Meeting of the Molecular Biology Society of Japan.

• Date: December 8, 2023 (Friday)
• Venue: Kobe Port Island
• Title: Analyzation of function of conserved Negative Charge Cluster on the surface of AIM molecule

※Affiliated with the Graduate School of Medicine, the University of Tokyo

We are pleased to announce our research papers have been published in scientific journals.

Yasuda K, Shimodan S, Maehara N, Hirota A, Iijima R, Nishijima A, Mori H, Toyama R, Ito A, Yoshikawa Y, Arai S, Miyazaki T. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. J Autoimmun. 2023, 142, 103149.

Research Fellow Kai Kudo* presented at the Research Meeting of Japan Health Foundation

• Date: November 11, 2023 (Saturday)
• Venue: Kyoto Tower Hotel
• Title: Discovery of a Novel Fatty Acid Desaturase Triggered by EBV Infection: Paving the Way for Medical Development

※Affiliated with Tokai University School of Medicine at the time of application and employment for the grant project

Research Fellow Kai Kudo* was awarded the "Encouragement Award" by the Japan Society of Clinical Chemistry (JSCC) in 2023.
*At the time of application, he was affiliated with Tokai University School of Medicine.

We are pleased to announce our research papers have been published in scientific journals.

Okanoue T, Yamaguchi K, Shima T, Mitsumoto Y, Katayama T, Okuda K, Mizuno M, Seko Y, Moriguchi M, Itoh Y, Miyazaki T. Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res. 2023, Online ahead of print.

Nemoto H, Honjo M, Arai S, Miyazaki T, Aihara M. Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension.
J Cell Physiol. 2023, Online ahead of print.

Director Miyazaki to Present at "Mirai Igaku Kenkyu Kai(Future Medicine Research Society^※)."

45th Mirai Igaku Kenkyu Kai Conference "think outside the box"
Special Lecture

• Date: July 8, 2023 (Saturday) 13:00-17:50
• Venue: Nihonbashi Life Science Hub 8F
• Presentation Title: The Day Cats Live to 30 and Human Dialysis Becomes Unnecessary: From the Discovery of AIM to Drug Development

※Official English translation is not available

Director Miyazaki Invited to Speak at the Japanese Society for Dialysis Therapy.

68th Annual Meeting of the Japanese Society for Dialysis Therapy
Special Lecture

• Date: June 18, 2023 (Sunday) 10:40-11:40
• Venue: Kobe Convention Center
• Title: Significance of Blood Protein AIM in the Diagnosis and Treatment of End-Stage Chronic Kidney Disease